• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

念珠菌血症重症患者的治疗。

Treatment of critically ill patients with candidemia.

作者信息

Mensa José, Pitart Cristina, Marco Francesc

机构信息

Infectious Diseases Department, Hospital Clínico, Barcelona, Spain.

出版信息

Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S93-7. doi: 10.1016/S0924-8579(08)70007-4.

DOI:10.1016/S0924-8579(08)70007-4
PMID:19013347
Abstract

Early initiation of effective antimicrobial therapy is crucial for the prognosis of any infection, especially in the critically ill patient. This is particularly true in the case of candidemia. However, the earlier an empirical antimicrobial regimen is started, the greater the probability of diagnostic error and the possibility of side-effects. Recent experience of the clinical efficacy and good tolerance of echinocandins in the treatment of candidemia obliges us to review the indications for empirical antifungal treatment and the choice of antifungal agent in the critically ill patient.

摘要

尽早开始有效的抗菌治疗对于任何感染的预后都至关重要,尤其是在危重症患者中。对于念珠菌血症而言尤其如此。然而,经验性抗菌治疗开始得越早,诊断错误的可能性和出现副作用的可能性就越大。棘白菌素类药物在治疗念珠菌血症方面的临床疗效和良好耐受性的最新经验促使我们重新审视危重症患者经验性抗真菌治疗的指征以及抗真菌药物的选择。

相似文献

1
Treatment of critically ill patients with candidemia.念珠菌血症重症患者的治疗。
Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S93-7. doi: 10.1016/S0924-8579(08)70007-4.
2
Timely selection of adequate antifungal therapy for candidemia in the critically ill: don't let the yeast rise!为重症患者的念珠菌血症及时选择合适的抗真菌治疗:别让酵母“发酵”!
Crit Care Med. 2008 Nov;36(11):3097-8. doi: 10.1097/CCM.0b013e31818b9375.
3
[Therapy of candidemia and invasive candidiasis according to guidelines].[根据指南进行的念珠菌血症和侵袭性念珠菌病治疗]
Mycoses. 2010 May;53 Suppl 1:30-5. doi: 10.1111/j.1439-0507.2009.01838.x.
4
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.2019例念珠菌血症患者的流行病学及转归:来自前瞻性抗真菌治疗联盟登记处的数据
Clin Infect Dis. 2009 Jun 15;48(12):1695-703. doi: 10.1086/599039.
5
Management of invasive Candida infections in non-neutropenic critically ill patients: from prophylaxis to early therapy.非中性粒细胞减少的重症患者侵袭性念珠菌感染的管理:从预防到早期治疗。
Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S137-41. doi: 10.1016/S0924-8579(08)70015-3.
6
Candidemia in the critically ill patient.危重症患者的念珠菌血症
Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S83-5. doi: 10.1016/S0924-8579(08)70005-0.
7
[Echinocandins in invasive candidiasis].[棘白菌素类药物治疗侵袭性念珠菌病]
Med Klin (Munich). 2008 Jun 15;103(6):397-405. doi: 10.1007/s00063-008-1058-3.
8
Antifungals in the ICU.重症监护病房中的抗真菌药物
Curr Opin Infect Dis. 2008 Dec;21(6):610-9. doi: 10.1097/QCO.0b013e3283177967.
9
Fluconazole prophylaxis for critically ill patients at high risk for Candida infection.对念珠菌感染高危的重症患者进行氟康唑预防治疗。
Clin Infect Dis. 2005 Dec 1;41(11):1690-1. doi: 10.1086/498349.
10
Multifocal Candida species colonization as a trigger for early antifungal therapy in critically ill patients: what about other risk factors for fungal infection?多灶性念珠菌属定植作为重症患者早期抗真菌治疗的触发因素:真菌感染的其他危险因素呢?
Crit Care Med. 2006 Mar;34(3):913-4. doi: 10.1097/01.CCM.0000202435.98240.ED.

引用本文的文献

1
Association of different Candida species with catheter-related candidemia, and the potential antifungal treatments against their adhesion properties and biofilm-forming capabilities.不同念珠菌物种与导管相关念珠菌血症的关系,以及针对其黏附特性和生物膜形成能力的潜在抗真菌治疗方法。
J Clin Lab Anal. 2021 Apr;35(4):e23738. doi: 10.1002/jcla.23738. Epub 2021 Feb 19.
2
Immune Response of against Human Fungal Pathogens.针对人类真菌病原体的免疫反应。 (注:原句中“of”后面缺少具体内容,这里是根据大概意思翻译)
J Fungi (Basel). 2018 Dec 26;5(1):3. doi: 10.3390/jof5010003.
3
Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013.
生物膜形成是2012 - 2013年苏格兰白色念珠菌血流感染患者死亡的一个危险因素。
Clin Microbiol Infect. 2016 Jan;22(1):87-93. doi: 10.1016/j.cmi.2015.09.018. Epub 2015 Sep 30.
4
Acetylcholine Protects against Candida albicans Infection by Inhibiting Biofilm Formation and Promoting Hemocyte Function in a Galleria mellonella Infection Model.在大蜡螟感染模型中,乙酰胆碱通过抑制生物膜形成和促进血细胞功能来抵御白色念珠菌感染。
Eukaryot Cell. 2015 Aug;14(8):834-44. doi: 10.1128/EC.00067-15. Epub 2015 Jun 19.
5
Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity.白色念珠菌血流分离株形成的生物膜表现出与耐药性和致病性相关的表型和转录异质性。
BMC Microbiol. 2014 Jul 5;14:182. doi: 10.1186/1471-2180-14-182.